Assessing the risk of hereditary breast cancer
Breast cancer is the most common cancer among women. In nearly 30 % of all cases, a member of the breast cancer patient’s extended family also has breast cancer. This may be coincidental or due to hereditary susceptibility.
According to estimates, a single gene mutation that runs in the family underlies approximately 5–10 % of all breast cancer cases. The most common form of such mutations are BRCA gene defects.
Indications of hereditary breast cancer include:
- Breast cancer in a very young person
- Multiple cancers in one person
- Breast cancer in both breasts
- Incidences of breast cancer and/or ovarian cancer in close kin
How can breast cancer heredity be examined?
How can the heredity of cancer be examined if you have a nagging doubt and have observed some of the indications mentioned above? At Docrates Cancer Center, we provide two alternative paths. A sensible approach is to discuss the cancer cases in your family with a specialist in medical genetics. If the situation seems to indicate the chance of hereditary breast cancer, a genetic test to investigate heredity will be recommended. The test is best suited for people who have actually already suffered from cancer. If a genetic defect is discovered, efforts will be made to identify all the carriers of the defective gene in the family. Even if a family shows hereditary susceptibility to cancer, it does not mean that all family members have inherited it.
However, if a customer wishes, another approach can also be adopted. A genetic risk test can be performed immediately on the basis of the customer’s concern or his or her own assessment, whereafter the situation and the significance of the test can be discussed with a geneticist when the results of the gene test are known. The interpretation of the results always depends on the patient’s and his or her family’s situation. In other words, if the genetic risk test does not reveal any harmful variant associated with an increased risk of developing cancer, it does not necessarily mean that the person in question could not have inherited cancer susceptibility, which is why he or she would require more accurate monitoring than usual.
Breakthroughs in the treatment of metastatic breast cancer
New forms of drug therapy can almost double the life expectancy of patients with advanced breast cancer and allow treatment...Read more
Docrates Cancer Center has appointed Anna-Sofia Malmi as Marketing and Communications Director
Anna-Sofia Malmi, M.Sc (Education), has been appointed as Marketing and Communications Director at Docrates Cancer Center and a member of...Read more
Accurate information on aggressiveness and tumor staging form the basis for prostate cancer treatment
In western countries, prostate cancer is the most common cancer type in men. In its early stages, it is often...Read more
Should low-risk prostate cancer be left to active monitoring?
Active treatment vs. monitoring of localised low-risk prostate cancer has long been a contested topic. According to the results of...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.